Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029
... Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029 The diagnostic specialty antibodies ... Read More
-
2022-2026 France Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
... suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test ... Read More
-
2022-2026 Italy Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
... suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test ... Read More
-
2022-2026 US Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
... suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test ... Read More
-
2022-2026 Global Infectious Disease Molecular Diagnostics Market for 100 Tests: US, Europe, Japan--Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
... to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets ... Read More
-
2022-2026 UK Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
... suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test ... Read More
-
2022-2026 Germany Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
... suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test ... Read More
-
South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The South & Central America monoclonal antibodies market is expected to reach US$ 10,847.3 million by ... Read More
-
Europe Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... and End User (Pediatric, ICU, Home Care, and Others) The Europe non-invasive ventilation masks market is expected to reach US$ 735.24 million by 2028 from US$ 515.45 million in 2021. The market is estimated to ... Read More
-
North America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The North America non-invasive ventilation masks market is expected to reach US$ 985.8 million by 2028 from US$ 671.1 million in 2021. The market is ... Read More
-
South and Central America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The South & Central America non-invasive ventilation masks market is expected to reach US$ 166.2 million by 2028 from US$ 119.8 million in ... Read More
-
Middle East and Africa Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The Middle East & Africa non-invasive ventilation masks market is expected to reach US$ 114.0 million by 2028 from US$ 84.2 million in ... Read More
-
Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Middle East & Africa monoclonal antibodies market is expected to reach US$ 5,741.1 million by ... Read More
-
Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026
... valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences ... Read More
-
Asia Pacific Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Asia Pacific monoclonal antibodies market is expected to reach US$ 44,729.7 million by 2028 from US$ 18,344.5 ... Read More
-
Hospital-Acquired Infection Diagnostics Market By Product (Instrument, Reagents and Consumables), By Test Type (Molecular Diagnostics, Immunoassay, Others), By Application (Disease Testing, Drug-Resistance Testing), By Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), Others), By End User (Hospital, Standalone Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
... Infections, Urinary Tract Infections (UTI), Others), By End User (Hospital, Standalone Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030 The global hospital acquired infection diagnostics market was valued $3,355.28 million in 2020 and expected ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis
... microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine an ... Read More
-
2022 Global Clinical Risk Grouping Solutions Industry (2028 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include ... Read More
-
Ventilator Associated Pneumonia (VAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline landscape. Ventilator-associated pneumonia (VAP) is pneumonia that develops ... Read More
-
Community Acquired Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline landscape. Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside a ... Read More
-
Smallpox Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Smallpox (Infectious Disease) pipeline landscape. Smallpox is an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, ... Read More
-
Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline landscape. Hospital Acquired Pneumonia (HAP) is defined as ... Read More
-
Global Oligonucleotide Synthesis Market Size study, By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, Equipment), By Application (Research Applications {PCR, Sequencing, Other Research Applications}, Diagnostic Applications), By Type (Antisense Oligonucleotide-Based Therapies, Rnai Oligonucleotide-Based Therapies, Cpg Oligonucleotide-Based Therapies, By Disease Type:, Neurological Disorders, Infectious Diseases, Other Diseases), By End-Use (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Cros And Cmos, Academic Research Institutes), and Regional Forecasts 2022-2028
... Therapies, By Disease Type:, Neurological Disorders, Infectious Diseases, Other Diseases), By End-Use (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Cros And Cmos, Academic Research Institutes), and Regional Forecasts 2022-2028Global Oligonucleotide Synthesis Market is valued approximately ... Read More
-
Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines), End User - Global Forecast to 2027
... estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of ... Read More
-
Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, DPT, Yellow Fever, Typhoid, Japanese Encephalitis, Measles Mumps & Rubella, Rabies, Polio, Influenza, Varicella & Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel)
... Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel) The travel vaccines market is projected to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021. It is estimated to grow ... Read More
Research Assistance
